Data from FDA - Curated by EPG Health - Last updated 27 July 2017

Indication(s)

INDICATIONS AND USAGE Thyreoidea compositum® Injection Solution is indicated for stimulation of the defense system in thyroid dysfunction, connective tissue dysfunction and glandular dysfunction.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Anticoagulation Therapy for Stroke Prevention

Anticoagulation Therapy for Stroke Prevention

Anticoagulation therapy for Stroke Prevention Learning Zone offers a deep-dive into atrial fibrillation causes, consequences, diagnosis and management to help you deliver optimal care and prevent strokes in patients living with this common arrhythmia.

Load more

Related Content

Usage information

Dosing and administration
DOSAGE AND ADMINISTRATION The dosage schedules listed below can be used as a general guide for the administration of Thyreoidea compositum® Injection Solution. Thyreoidea compositum® Injection Solution shows individual differences in clinical response. Therefore, the dosage for each patient should be individualized according to the patient’s response to therapy. Adults and children 7 years and older: in acute disorders, 1 ampule per day, otherwise 1 ampule, 1 to 3 times per week IM/SC/IV/ID.Children ages 2 to 6 receive ½ the adult dosage. Discard unused solution. Thyreoidea compositum® Injection Solution may be administered intravenously, intramuscularly, subcutaneously, or intradermally. The required dose of Thyreoidea compositum® Injection Solution is first withdrawn from the ampule into the syringe, and the syringe is then shaken briefy. Thyreoidea compositum® Injection Solution should be administered using a narrow gauge needle (e.g. 22 to 30 gauge). Note: Parental drug products like Thyreoidea compositum® Injection Solution should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Thyreoidea compositum® Injection Solution is a clear, colorless solution. Discolored solutions should be discarded.

More information

Category Value
Agency product number 6CA025Y4FG
Orphan designation No
Product NDC 50114-7041
Date Last Revised 08-07-2011
Type HUMAN PRESCRIPTION DRUG
Marketing authorisation holder Heel Inc